進階篩選

Technical category
技術研發單位
    • 5D智慧城市─SmartES平台

      AI & IOT Application FutureTech 5D智慧城市─SmartES平台

      NCREE has originally developed 5D digital space—on the basis of 3D city modelsconnections of different kinds of sensors around the world— is an online to offline virtual space with a combination of rising 5G technology advantages. Collectingreorganizing various 3D cartographic data with Building Information Modeling (BIM), satellite imagery, UAV 3D modeling, LiDar point cloud data, etc., can increase the diversity of the buildinglandscape. 5D+5G smart city platform would accelerate the 5D smart city to become the digital twin of a real city.
    • 突破物聯網的最後一哩:無晶片射頻辨識

      Electronic & Optoelectronics FutureTech 突破物聯網的最後一哩:無晶片射頻辨識

      The major cost of conventional RFID tags comes from a microchip. To reduce the start-up cost, we develop a chipless RFID system that eliminates the use of the chip. This research organize the real-world issues of chipless RFID into four subjects, including the design of chipless tags, chipless RFID readers, reader signal processing,wireless propagation channel. We successfully integrate the four topics, developing a calibration-free, orientation-insensitive,high-capacity chipless RFID system with multi-tag detection capability.
    • 人工智慧自動化優質細胞選取精進平台

      FutureTech 人工智慧自動化優質細胞選取精進平台

      Induced pluripotent stem cells are a promising new technology in translation medicine,AI technology is an automaticpowerful platform that can help identify cell images with unique characteristics, predictprovide information about cell types, differentiation stages, cell quality,normal Or disease-specific feature information. The combination of this induced pluripotent stem cell differentiation platformAI-based artificial intelligence image analysis technology will have great benefits for future cell product applications.
    • 非病毒磁性基因傳遞技術及其細胞治療應用

      FutureTech 非病毒磁性基因傳遞技術及其細胞治療應用

      Gene delivery technology is widely used in cell therapy, nucleic acid-based vaccines, protein production, gene therapy, etc. We have developed a non-viral gene delivery technology-MPGene, which has excellent gene delivery efficiency (50-80) for human mesenchymal stem cells,also has the characteristics of low production costhigh safety. In the future, MPGene has the potential to be used in important biomedical fields such as gene delivery reagents, major trauma cell therapy, malignant tumor treatmentcartilage cell therapy.
    • A Kinase Inhibitor that Induces Degradation of MYC Oncoprotein

      Precision Health Ecosystem FutureTech A Kinase Inhibitor that Induces Degradation of MYC Oncoprotein

      This technology is a development drug lead aiming to meet the medical needs of patients with small cell lung cancer. Through disturbing MYC-Aurora A interaction and inducing degradation of MYC oncoprotein, this bioavailable kinase inhibitor could serve as a potential treatment entity for SCLC.